Back to top

Covid-19 Impact on Addiction Treatment: Survey Findings & Implications​

Share this on:

Join a collaborative discussion between Peter Thomas, Director of Quality Assurance at NAATP, and Reyna Taylor, VP of Public Policy and Advocacy at NCBH, as they review findings from their respective COVID-19 Impact Surveys, which polled the addiction field to measure the myriad ways the pandemic has affected treatment organizations. Presenters will begin by discussing the “big picture” takeaways for treatment to date, offer detailed datapoints gathered from survey responses, and wrap up by empowering attendees to take action and advocate for the near- and long-term stability and success of the addiction treatment field.

Peter Thomas and Reyna Taylor

Peter Thomas is the Director of Quality Assurance for the National Association of Addiction Treatment Providers (NAATP) ensuring the quality of membership and services. He brings six years experience working in addiction treatment including roles in direct patient care, administration and executive leadership. Prior to accepting a role with NAATP, Peter worked as the Chief Operating Officer for Chapter 5 Counseling Center. Peter has dedicated much of his time to working with industry representatives and legislators to enhance access to quality behavioral health care in Arizona. He has served as President for the Northern Arizona Recovery Association, (NARA) and co-founded the Arizona Addiction Advocacy Coalition (AAAC). Through these roles Peter assisted in drafting and passage of state legislation protecting addiction treatment consumers while also enhancing the efficacy and reputation of providers.

Reyna Taylor brings extensive experience with federal public policy initiatives to protect access and affordability to her role as Vice President of Public Policy and Advocacy at the National Council for Behavioral Health where she leads public policy and government affairs activities, supervises legislative matters and guides overall public policy strategy. With nearly two decades of specialty pharmaceutical and medical device experience, Ms. Taylor has a wide range of knowledge on public policy issues, including Medicare, Medicaid and commercial management of managed care organizations, hospitals, pharmacies and mental health centers. She holds a Bachelor of Science in neuroscience from Bates College and earned a Master of Science in biotechnology and Master of Business Administration from Johns Hopkins University.

Date & Time: 
Thursday, October 22, 2020 11:00 am to 12:00 pm